Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
Bioorganic & Medicinal Chemistry Letters|August 17, 2023
6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptorGary E Aspnes, Scott W Bagley, Steven B Coffey, et al.
Annals of the Rheumatic Diseases|February 9, 2006
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitisT Pham, R Landewé, S van der Linden, et al.
The Journal of Organic Chemistry|November 7, 2012
Synthesis of spiropiperidine lactam acetyl-CoA carboxylase inhibitorsKim Huard, Scott W Bagley, Elnaz Menhaji-Klotz, et al.
Applied and Environmental Microbiology|May 29, 2007
Ecological genomics of marine RoseobactersM A Moran, R Belas, M A Schell, et al.
ACS Medicinal Chemistry Letters|October 18, 2023
Design of Next-Generation DGAT2 Inhibitor PF-07202954 with Longer Predicted Half-LifeKevin J Filipski, David J Edmonds, Michelle R Garnsey, et al.
Journal of Medicinal Chemistry|April 4, 2015
Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) AgonistsHuy N Hoang, Kun Song, Timothy A Hill, et al.
Journal of Medicinal Chemistry|August 29, 2013
Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structureDavid A Griffith, Robert L Dow, Kim Huard, et al.
ACS Medicinal Chemistry Letters|October 15, 2014
Cyclic Penta- and Hexaleucine Peptides without N-Methylation Are Orally AbsorbedTimothy A Hill, Rink-Jan Lohman, Huy N Hoang, et al.
Journal of Medicinal Chemistry|June 1, 2022
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 ReceptorDavid A Griffith, David J Edmonds, Jean-Philippe Fortin, et al.
Pageof 26